Peg -- BRIAN McKay, PhD at the University of Arizona.

Yes, they would use the patient's own retinal cells, implant them in the brain, and have them produce dopamine. I had wondered about the possibility of rejection in the Spheramine trial -- glad they have a method of precluding that.

Anyway it's exciting to see that this level is research is going on in Tucson. When they start phase I trials, i'll be at the head of the line (unless there is a ceregene phase III trial first ... ).

best,